JP2021536462A5 - - Google Patents
Info
- Publication number
- JP2021536462A5 JP2021536462A5 JP2021512448A JP2021512448A JP2021536462A5 JP 2021536462 A5 JP2021536462 A5 JP 2021536462A5 JP 2021512448 A JP2021512448 A JP 2021512448A JP 2021512448 A JP2021512448 A JP 2021512448A JP 2021536462 A5 JP2021536462 A5 JP 2021536462A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- heterocyclyl
- cycloalkyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862728203P | 2018-09-07 | 2018-09-07 | |
| US62/728,203 | 2018-09-07 | ||
| PCT/US2019/049971 WO2020051465A1 (en) | 2018-09-07 | 2019-09-06 | Hybrid amphotericin b derivatives with reduced toxicity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021536462A JP2021536462A (ja) | 2021-12-27 |
| JP2021536462A5 true JP2021536462A5 (https=) | 2022-09-09 |
| JP7477177B2 JP7477177B2 (ja) | 2024-05-01 |
Family
ID=69719049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512448A Active JP7477177B2 (ja) | 2018-09-07 | 2019-09-06 | 毒性が低減されたハイブリッドアムホテリシンｂ誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11198705B2 (https=) |
| EP (1) | EP3846823A4 (https=) |
| JP (1) | JP7477177B2 (https=) |
| KR (1) | KR102893040B1 (https=) |
| CN (1) | CN113056274A (https=) |
| AU (1) | AU2019335409B2 (https=) |
| CA (1) | CA3111565A1 (https=) |
| WO (1) | WO2020051465A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3111565A1 (en) | 2018-09-07 | 2020-03-12 | The Board Of Trustees Of The University Of Illinois | Hybrid amphotericin b derivatives with reduced toxicity |
| KR20220058547A (ko) * | 2019-08-08 | 2022-05-09 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 감소된 독성을 갖는 하이브리드 암포테리신 b 유도체 |
| AU2021325676A1 (en) * | 2020-08-10 | 2023-03-30 | The Board Of Trustees Of The University Of Illinois | Hybrid amide derivatives of amphotericin B |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102548341B1 (ko) * | 2013-10-07 | 2023-06-26 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 개선된 치료 지수를 갖는 암포테리신 b 유도체 |
| ES2749927T3 (es) * | 2014-05-16 | 2020-03-24 | Univ Illinois | Derivado de anfotericina b con toxicidad reducida |
| MA39568A1 (fr) * | 2014-06-12 | 2017-09-29 | Shionogi & Co | Dérivé de macrolide de polyène |
| JP7240811B2 (ja) * | 2015-04-15 | 2023-03-16 | スファンガ セラピューティクス インコーポレイテッド | アムホテリシンｂの誘導体 |
| WO2017100171A1 (en) * | 2015-12-08 | 2017-06-15 | Kalyra Pharmaceuticals, Inc. | Antifungal compounds and methods |
| CA3111565A1 (en) | 2018-09-07 | 2020-03-12 | The Board Of Trustees Of The University Of Illinois | Hybrid amphotericin b derivatives with reduced toxicity |
-
2019
- 2019-09-06 CA CA3111565A patent/CA3111565A1/en active Pending
- 2019-09-06 KR KR1020217010183A patent/KR102893040B1/ko active Active
- 2019-09-06 EP EP19856633.3A patent/EP3846823A4/en active Pending
- 2019-09-06 US US16/563,243 patent/US11198705B2/en active Active
- 2019-09-06 AU AU2019335409A patent/AU2019335409B2/en active Active
- 2019-09-06 CN CN201980072996.8A patent/CN113056274A/zh active Pending
- 2019-09-06 WO PCT/US2019/049971 patent/WO2020051465A1/en not_active Ceased
- 2019-09-06 JP JP2021512448A patent/JP7477177B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021536462A5 (https=) | ||
| JP2020505396A5 (https=) | ||
| RU2006131132A (ru) | 1,3,5,-тризамещенные производные 4,5-дигидро-1н-пиразола, обладающие св1-антагонистической активностью | |
| KR930702292A (ko) | 종양 치료 활성을 증대시키기 위한 퀴나졸린 유도체 | |
| KR101605151B1 (ko) | 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드 | |
| JP2003500404A5 (https=) | ||
| JP2008509166A5 (https=) | ||
| RU2006134003A (ru) | Серосодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с | |
| RU2011132118A (ru) | Ингибиторы axl для применения в комбинированной терапии для предотвращения, устранения или лечения метастизирующего рака | |
| KR20100080516A (ko) | 아레나바이러스 감염을 치료하기 위한 항바이러스 약물 | |
| US20200392098A1 (en) | SUBSTITUTED NAPHTHO[2,3-b]FURANS AS WATER-SOLUBLE PRODRUGS FOR PREVENTING AND/OR TREATING CANCER | |
| JP2005507923A (ja) | Ｃｃｒ１受容体アンタゴニスト活性を有するピペラジン誘導体 | |
| RU94030812A (ru) | Производные фосфоноянтарной кислоты, способ их получения и содержащие эти соединения фармацевтические композиции | |
| RU95113148A (ru) | Производное 2-(2-амино-1,6-дигидро-6-оксопурин-9-ил)-метокси-1,3-пропандиола | |
| JP2006506391A (ja) | Ｃｃｒ１アンタゴニストとしてのピペラジン誘導体の使用 | |
| JP5179190B2 (ja) | 神経変性疾病の治療において１，４−ビス（３−アミノアルキル）ピペラジン誘導体を使用する方法 | |
| JP2022502370A (ja) | 置換ピリジニル化合物およびその使用 | |
| TNSN04188A1 (fr) | NOUVEAUX DERIVES D'INDOLIZINE 1,2,3 SUBSTITUEE, INHIBITEURS DES FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT | |
| JP2023525359A5 (https=) | ||
| JP2024540303A5 (https=) | ||
| KR940014332A (ko) | 레트로비루스성 프로테아제 효소의 저해제로서 유용하고 항-hiv제로서 작용하는 신규한 화합물 및 이들의 생산 방법 | |
| CZ140696A3 (en) | Hiv protease inhibitor precursors and pharmaceutical compositions containing thereof | |
| JP2005511535A5 (https=) | ||
| US20020198189A1 (en) | New use | |
| US3755584A (en) | Tranquilizers |